Home > SANTE - SCIENCES DE LA VIE > Biotechnologies Et Génétique > Combinatorics
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Biotechnologies Et Génétique > Etude de marché sectorielle
 Combinatorics
€ 1 400,00
Editeur :
ZZZ - Biovista
Langue :
Anglais
Date de publication :
Décembre 2000
Taille du document :
150
Autres informations :
Description , Table des matières
 

Recevez cette publication aujourd'hui !
Price : EUR 1 400,00
Plus d'information ?
+33 437 37 1637
 
Documents Publics
1,200,000 documents
Téléchargement illimités
 
Etudes Privées
50,000 rapports et études
Paiement à la piéce
 
1.Télécharger nos rapports publics

Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...

Nos documents publics sur le même théme (3)
Jewels and Watches market in India
41 pages | Août 2006 | Anglais
 
 
   
Main focus: jewellery,watch,watches,clocks,jewelry,jewel,...
Research focus: market size and estimates,market segmentation,
Geographic focus: india,usa,switzerland,france,malaysia,netherlands
   
Jewels and Watches market in USA
48 pages | Décembre 2006 | Anglais
 
 
   
Main focus: watch,information technology
Research focus: market outlook,market definition,
Geographic focus: usa,canada,united kingdom,france,brazil,croatia,...
   
Jewels and Watches market in Singapore and Malaysia
77 pages | Juin 2005 | Anglais
 
 
   
Main focus: watch,watches,clocks,luxury watches,luxury watch,...
Research focus: market size and estimates,competition analysis,
Geographic focus: singapore,malaysia,usa,hong kong,indonesia,...
   
Autres recherches sur le même thème
Rechercher d'autres rapports publics à télécharger
 
 
 
2. Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Biotech Industry Potential: Emerging Markets & Trends
15 pages | Novembre 2002 |
The global biotech industry is comprised of 4,284 companies in 25 nations.
The 622 public companies generated revenues of $35 billion, spent $16 billion in R&D and employed more than 188,000 people
250,00 €
 
 
Strategies for Biogeneric Success
71 pages | Juin 2004 |
What will determine success? Development of biogeneric molecules for sale in the potentially highly lucrative US and Western European markets depends on the ability to answer three key questions
1 500,00 €
 
 
Signal Transduction
170 pages | Décembre 2000 |
Novel drug targets are emerging from the elucidation of the molecular chain reactions that underlie the responses of cells to their environment.
Signal transduction is the term describing the p
1 400,00 €
 
 
03-011: The Market for Real-Time PCR Reagents & Instrumentation
180 pages | Avril 2003 |
Based on a detailed 52-question survey of 406 scientists who currently perform qPCR, this report describes their research interests and specific applications
640,00 €
 
 
03-052A: Protein Purification Systems: Market Opportunities for Research Product Suppliers
163 pages | Octobre 2003 |
This report will help suppliers exploit opportunities to differentiate themselves from their competitors and develop more advanced protein purification tools
960,00 €
 
 
03-038: Clinical Proteomics: A First-Glance Market Report
96 pages | Septembre 2003 |
his First-Glance Market Report identifies the research objectives, methodologies, assay parameters and technological limitations that are currently associated with disease-based protein-profiling stud
400,00 €
 
 
Biochips IRCD
pages | Juillet 2001 |
The notion of a cheap and reliable computer chip look-alike that performs thousands of biological reactions is a very attractive one, because it miniaturizes, automates and accelerates otherwise cumbe
1 200,00 €
 
 
Pharmacogenomics IRCD
pages | Juillet 2001 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which are
1 200,00 €
 
 
Antisense Therapy: Technical Aspects and Commercial Opportunities
334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process.
Besides the well known oligonucleotides (
955,00 €
 
 
Arthritis Drug Discovery IRCD
pages | Juin 2001 |
Arthritis (from the Greek for joint) is a chronic multi-factorial disease of the joints, induced when the immune system attacks and begins degrading the joints.
The disease knows no racial boun
1 026,17 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 Combinatorics

Identified by The Economist (*) as the industry to watch for 1997 in the chemicals
 

 
sector, Combinatorics (also known as combinatorial chemistry) is an emerging
 

 
platform technology that uses test tube evolution to rapidly generate libraries
 

 
of new drug candidates from which those with the right properties are selected.
 

 


 

 
Reducing substantially research costs, the scope and reach of this technology
 

 
which represents an industry worth well over $2 billion, is enormous. (*)

 

 
The Economist: The World in 1997, page 94 The Industry Review and Company Database
 

 
on Combinatorics has the following aims:

 

 
· to introduce and describe the essential elements of Combinatorics as
 

 
a platform technology

 

 
· to introduce and describe the essential elements of Combinatorics as
 

 
a platform business

 

 
· to provide the most comprehensive listing available of companies using
 

 
Combinatorics

 

 
· to serve as a business networking node in the Combinatorics arena


 

Executive Summary

Aims and Scope

IRCD Structure

PART 1: TECHNOLOGY

Combinatorics Technology

Definitions

Process description

Combinatorics for new drugs

Library synthesis approaches

Combinatorics information management

PART 2: BUSINESS USERS AND MARKET

Combinatorics Commercialization

Financial emergence of Combinatorics

Raising capital for Combinatorics

Tool vs. target

Strategic developments

Corporate activity in 1998

Synopsis of notable events in 1998

Descriptions of 1998's corporate activities

Discussion of 1998's corporate activities

Combinatorics consortia

Intellectual property issues

Clinical efforts

Future financing trends

Reference list

PART 3: COMPANIES

Methodology

Concise Company Listing

Extended Company Listing

PART 4: PATENTS

Methodology

Concise Patent Listing

Extended Patent Listing


New Search:

PPLSEN